EDGAR Filing Documents for 0001399529-20-000022

Form 8-K - Current report:

SEC Accession No. 0001399529-20-000022

Filing Date

2020-04-06

Accepted

2020-04-06 07:03:47

Documents

Period of Report

2020-04-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	drna_20200406x8k.htm	8-K	40390
2	EXHIBIT 99.1	dassia_prxfinal.htm	EX-99.1	40778
3		dassiaprfinalimage1.gif	GRAPHIC	4578
4		dassiaprfinalimage2.gif	GRAPHIC	6086
	Complete submission text file	0001399529-20-000022.txt		97227

Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097

Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 20775704
SIC: 2834 Pharmaceutical Preparations